These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2551151)

  • 1. Effects of PAF and PAF antagonists on the shape of venous endothelial cells in vitro.
    Northover AM
    Agents Actions; 1989 Aug; 28(1-2):142-8. PubMed ID: 2551151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro effects of PAF on venous endothelial cell actin disposition.
    Northover AM
    Agents Actions; 1992 Jan; 35(1-2):40-9. PubMed ID: 1509977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists.
    Piper PJ; Stewart AG
    Br J Pharmacol; 1987 Apr; 90(4):771-83. PubMed ID: 3034369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of Paf antagonists on bronchial hyperresponsiveness induced by Paf, propranolol or indomethacin.
    Dixon EJ; Wilsoncroft P; Robertson DN; Page CP
    Br J Pharmacol; 1989 Jul; 97(3):717-22. PubMed ID: 2758238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference of WEB 2086 and BN 52021 with Paf-induced effects on guinea-pig trachea.
    Brunelleschi S; Renzi D; Ledda F; Giotti A; Fantozzi R; Brink C; Benveniste J
    Br J Pharmacol; 1989 Jun; 97(2):469-74. PubMed ID: 2758225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of TMB-8 on the shape changes of vascular endothelial cells resulting from exposure to various inflammatory agents.
    Northover AM
    Agents Actions; 1989 Mar; 26(3-4):367-71. PubMed ID: 2500011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Platelet-activating factor (PAF) antagonists].
    Terasawa M
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary hypertension and edema induced by platelet-activating factor in isolated, perfused rat lungs are blocked by BN52021.
    Imai T; Vercellotti GM; Moldow CF; Jacob HS; Weir EK
    J Lab Clin Med; 1988 Feb; 111(2):211-7. PubMed ID: 3339274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of PAF-induced death in mice.
    Myers AK; Nakanishi T; Ramwell P
    Prostaglandins; 1988 Mar; 35(3):447-58. PubMed ID: 3131837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of platelet-activating factor on porcine pulmonary blood vessels in vitro.
    Pritze S; Simmet T; Peskar BA
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):495-9. PubMed ID: 1766475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of the coronary vascular effects of platelet-activating factor in the rat perfused heart.
    Hu W; Kinnaird AA; Man RY
    Br J Pharmacol; 1991 May; 103(1):1097-102. PubMed ID: 1652337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of platelet-activating factor on flow rate and eicosanoid release in the isolated perfused rat gastric vascular bed.
    Dembinska-Kiec A; Peskar BA; Muller MK; Peskar BM
    Prostaglandins; 1989 Jan; 37(1):69-91. PubMed ID: 2717778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paf-induced release of spasmogens from guinea-pig lungs.
    Jancar S; Thériault P; Lauzière M; Braquet P; Sirois P
    Br J Pharmacol; 1989 Jan; 96(1):153-62. PubMed ID: 2538179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
    Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M
    Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification by some antagonists of the shape changes of venous endothelial cells in response to inflammatory agents in vitro.
    Northover AM
    Agents Actions; 1990 Mar; 29(3-4):184-8. PubMed ID: 2111079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet activating factor induces dopamine release in PC-12 cell line.
    Bussolino F; Tessari F; Turrini F; Braquet P; Camussi G; Prosdocimi M; Bosia A
    Am J Physiol; 1988 Oct; 255(4 Pt 1):C559-65. PubMed ID: 3177629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of platelet activating factor antagonists on cultured rat mesangial cells.
    Neuwirth R; Singhal P; Satriano JA; Braquet P; Schlondorff D
    J Pharmacol Exp Ther; 1987 Nov; 243(2):409-14. PubMed ID: 3119816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CIS-19, a novel platelet activating factor receptor antagonist: in vitro and in vivo studies.
    Ko FN; Yu SM; Chen IS; Ishii H; Chang YL; Huang TF; Teng CM
    Biochim Biophys Acta; 1993 Jan; 1175(2):225-31. PubMed ID: 8380343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gossypol: a potent inhibitor of PAF-acether- and leukotriene-induced contractions of guinea-pig lung parenchyma strips.
    Touvay C; Vilain B; Sirois P; Soufir M; Braquet P
    J Pharm Pharmacol; 1987 Jun; 39(6):454-8. PubMed ID: 2886603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of indomethacin and verapamil on the shape changes of vascular endothelial cells resulting from exposure to various inflammatory agents.
    Northover AM
    Agents Actions; 1988 Jul; 24(3-4):351-5. PubMed ID: 3177095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.